Month: June 2025

Form 8.3 – AXA INVESTMENT MANAGERS: Empiric Student Property Plc

Written by Customer Service on June 6, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: AXA Investment Managers S.A.(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Empiric Student Property plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For...

Foxx Development Poised to Join Russell Microcap Index

Written by Customer Service on June 6, 2025. Posted in Public Companies.

Irvine, CA, June 06, 2025 (GLOBE NEWSWIRE) — Foxx Development Holdings Inc. (“Foxx Development” or “Company”) (Nasdaq: FOXX), a leading provider of consumer electronics and integrated Internet-of-Things (IoT) solutions for retail and institutional clients, today announced that the Company will be included in the Russell Microcap® Index following FTSE Russell’s preliminary 2025 annual reconstitution list. Foxx is among the telecommunications companies slated to join the list, representing a significant milestone for the Company. The newly reconstituted indexes will take effect after U.S. market close on June 27. The Russell Microcap® Index is completely reconstituted annually to ensure new and growing equities are reflected and companies included continue to reflect appropriate capitalization and value characteristics. After...

Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC

Written by Customer Service on June 6, 2025. Posted in Public Companies.

Moderated webcast fireside chat with members of Senti management and Chardan senior research analyst, Geulah Livshits, PhD on Monday, June 9th at 3:00 PM ET SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it will participate in a Virtual Fireside Chat hosted by Chardan Capital Markets, LLC on Monday, June 9, 2025 at 3:00 PM ET. For the fireside chat, Timothy Lu, M.D., Ph.D. Co-Founder and Chief Executive Officer, Kanya Rajangam, M.D., Ph.D. President, Head of Research & Development and Chief Medical Officer, and Jay Cross, Chief Financial Officer of Senti Biosciences will join Chardan senior...

Virco Reports $700,000 First Quarter Profit as Demand for School Furniture Slows

Written by Customer Service on June 6, 2025. Posted in Earnings Releases And Operating Results.

Shipments plus Backlog declines 22.9% to $105.6 million Gross Margin Improves 400 Basis Points to 47.5% vs. 43.5% LY Reinforcing Company’s Long-Standing Commitment to Domestic Manufacturing Board Declares Quarterly Dividend of $0.025 per Share, payable July 11, 2025 to Shareholders of Record as of June 20, 2025 First quarter shareholder returns reach $4.4 million, including buybacks and dividendsTORRANCE, Calif., June 06, 2025 (GLOBE NEWSWIRE) — Virco Mfg. Corporation (NASDAQ: VIRC), a leading manufacturer and direct supplier of moveable furniture and equipment for educational environments and public spaces in the United States, reported a modest profit despite slowing demand during the Company’s first quarter ended April 30, 2025. Through three months, net income was $0.7 million versus $2.1 million for the comparable period...

Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus

Written by Customer Service on June 6, 2025. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced the appointment of Shawn Rose, M.D. Ph.D., as its next Chief Medical Officer (CMO) and Head of Research and Development (R&D) starting on June 23, 2025. He replaces David R. Shook, M.D., who will be stepping down from the role to pursue other opportunities in the oncology space. Dr. Rose has dedicated his career to immunology translational medicine and advancing new treatment options for autoimmune patients. In various leadership roles, he has brought forward more than a dozen programs from discovery into clinical development, and he has developed multiple pioneering approved medicines such...

Cycurion Reports Financial Results for the First Quarter 2025

Written by Customer Service on June 6, 2025. Posted in Earnings Releases And Operating Results.

MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, reports financial results for the first quarter ended March 31, 2025, and provides a corporate update. Financial HighlightsRevenues of $3.9 million. Gross Profit of $677,673, up 95.4% year-over-year, with a 17.5% gross margin increase in the first quarter of 2025 compared to $346,714 (8.2% gross margin) in the first quarter of 2024, reflecting a focus on capturing and retaining more profitable business. Adjusted EBITDA of $245,062 (6.3% margin) in the first quarter of 2025 compared to $(68,803) in the first quarter of 2024, reflecting strong cost management coupled with both scalable operating leverage and an optimized service mix that included a higher proportion of...

Hurco Reports Second Quarter Results for Fiscal Year 2025

Written by Customer Service on June 6, 2025. Posted in Earnings Releases And Operating Results.

INDIANAPOLIS, June 06, 2025 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the second fiscal quarter ended April 30, 2025. Hurco recorded a net loss of $4,063,000, or $0.62 per diluted share, for the second quarter of fiscal year 2025, which included a non-cash tax valuation allowance of $1,270,000 recorded in provision for income taxes. This net loss of $4,063,000 for the second quarter of fiscal 2025 compared to a net loss of $3,922,000, or $0.61 per diluted share, for the corresponding period in fiscal year 2024. For the first six months of fiscal year 2025, Hurco reported a net loss of $8,383,000, or $1.29 per diluted share, compared to a net loss of $5,570,000, or $0.86 per diluted share, for the corresponding period in fiscal year 2024. The net loss for the first six months of fiscal 2025...

Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami

Written by Customer Service on June 6, 2025. Posted in Public Companies.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Goldman Sachs 46th Global Healthcare Conference, which will be held in Miami, Florida June 9-11, 2025. Members of the management team will host one-on-one meetings at the conference. Dr. Balaji Prasad, Chief Strategy Officer, will participate in a fireside chat on Wednesday June 11, 2025, at 8:00 am EDT (12:00 GMT / 14:00 CEST). A live webcast of the fireside chat will be available to the general public and can be accessed at https://investors.alvotech.com/events/event-details/goldman-sachs-46th-global-healthcare-conference-miami. After the event, a recording will be available for replay for 90 days. About AlvotechAlvotech is a biotech company, founded...

Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami

Written by Customer Service on June 6, 2025. Posted in Public Companies.

REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Goldman Sachs 46th Global Healthcare Conference, which will be held in Miami, Florida June 9-11, 2025. Members of the management team will host one-on-one meetings at the conference. Dr. Balaji Prasad, Chief Strategy Officer, will participate in a fireside chat on Wednesday June 11, 2025, at 8:00 am EDT (12:00 GMT / 14:00 CEST). A live webcast of the fireside chat will be available to the general public and can be accessed at https://investors.alvotech.com/events/event-details/goldman-sachs-46th-global-healthcare-conference-miami. After the event, a recording will be available for replay for...

Safe Harbor Financial to Participate in the Benzinga Cannabis Capital Conference on June 8–10, 2025

Written by Customer Service on June 6, 2025. Posted in Public Companies.

DENVER, June 06, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (Safe Harbor or the “Company”) (Nasdaq: SHFS), a fintech leader in facilitating financial services and credit facilities to the cannabis industry, announced that Terry Mendez, Safe Harbor’s Chief Executive Officer, Jeffrey Kay, Senior Vice President of Marketing, Dominic Marella, Vice President of Business Development, and Michael Regan, Head of Investor Relations & Data Science will participate in the Benzinga Cannabis Capital Conference being held on June 8–10, 2025, at the Marriott Magnificent Mile in Chicago, Illinois. Terry Mendez, will join a panel discussion titled “The CFO, The CPA & The CEO: How To Make Your Business Financially Resilient” on Monday, June 9, 2025, at 1:00 p.m. CT on the Main Stage on Floor 5 (Chicago Ballroom...

Month: June 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals